Post-translational regulation of steroidogenesis and its clinical relevance in hormone responsive cancers

Roopika Sankar1, Ganesh Venkatraman1

  • 1Department of Bio-Medical Sciences, School of Bio Sciences and Technology, Vellore Institute of Technology, Vellore, Tamil Nadu, India.

Seminars in Oncology
|June 11, 2026
PubMed

Insights

This study details key enzymes in hormone synthesis, revealing how their regulation impacts hormone-related cancers. Understanding these steroidogenic pathways offers new targets for cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Hormone-related cancers are a major global health issue with high mortality.
  • Steroidogenesis, the hormone synthesis pathway, is crucial in cancer development and progression.
  • Enzyme dysregulation and post-translational modifications significantly influence cancer cell behavior.

Purpose of the Study:

  • To comprehensively analyze the function and regulation of key steroidogenic enzymes and StAR.
  • To integrate information on expression, domains, post-translational modifications, and involved kinases.
  • To identify novel therapeutic targets for hormone-related cancers.

Main Methods:

  • Bioinformatic analysis of steroidogenic enzymes (Desmolase, 17α-hydroxylase, 3β-HSD, 17β-HSD) and StAR.
  • Examination of enzyme expression patterns and domain architectures.
  • Compilation of known post-translational modification sites and associated kinases.

Main Results:

  • Detailed functional and regulatory insights into four key steroidogenic enzymes and StAR.
  • Integrated overview of expression, structure, and post-translational modifications.
  • Identification of specific kinases modulating enzyme activity and stability.

Conclusions:

  • Elucidation of molecular details provides a foundation for understanding enzyme roles in cancer.
  • Disruptions in steroidogenesis and enzyme regulation are critical in hormone-related cancers.
  • This research opens new avenues for targeted therapeutic strategies in oncology.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...